Gastrointestinal mucosal findings in patients receiving mycophenolic acid (MPA) as demonstrated by small bowel capsule endoscopy (SBCE)

Trial Profile

Gastrointestinal mucosal findings in patients receiving mycophenolic acid (MPA) as demonstrated by small bowel capsule endoscopy (SBCE)

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2016

At a glance

  • Drugs Mycophenolate mofetil; Mycophenolic acid
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Mar 2016 Protocol amended as treatment arms changed from 2 to 1, Study design changed from parallel to single group assignment as reported by ClinicalTrials.gov.
    • 03 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top